Tempus expands multi-year collaboration with Gilead for oncology research
Go back to Tempus expands multi-year collaboration with Gilead for oncology research| Gilead Sciences (NASDAQ: GILD) | Delayed: 145.65 -0.99 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.64 | 52 Week High | $108.63 | |||
| Open | $145.46 | 52 Week Low | $71.39 | |||
| Day High | $147.68 | P/E | 80.47 | |||
| Day Low | $145.00 | EPS | $1.81 | |||
| Volume | 4,583,215 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 61.28 -3.01 (4.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.29 | 52 Week High | $0.45 | |||
| Open | $63.42 | 52 Week Low | $0.37 | |||
| Day High | $64.91 | P/E | N/A | |||
| Day Low | $60.93 | EPS | $-0.31 | |||
| Volume | 6,619,040 | |||||
